CAS 1009119-83-8

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Virtual Booth

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

CHEMISTRY

Discover Molecule Insights

BUILDING BLOCK

1 Suppliers, 1 End Use APIs, 7 Related Intermediates

1 Suppliers
1 End Use APIs
7 Related Intermediates

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1009119-83-8, Hcv-in-29, 2-[(2s)-pyrrolidin-2-yl]-5-[4-[4-[2-[(2s)-pyrrolidin-2-yl]-1h-imidazol-5-yl]phenyl]phenyl]-1h-imidazole;tetrahydrochloride, 4,4'-bis(2-((s)-pyrrolidin-2-yl)-1h-imidazol-5-yl)-1,1'-biphenyl 4hcl, 1h-imidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2s)-2-pyrrolidinyl-, hydrochloride (1:4), 2-((2s)-pyrrolidin-2-yl)-5-(4-(4-(2- ((2s)-pyrrolidin-2-yl)-1h-imidazol -5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride

Molecular Formula

C₂₆H₃₂Cl₄N₆

Molecular Weight

570.4 g/mol

InChI Key

AYOXSBJGFNPGNK-VDUNKYASSA-N

1 2D Structure

CAS 1009119-83-8

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[(2S)-pyrrolidin-2-yl]-5-[4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazole;tetrahydrochloride

2.1.2 InChI

InChI=1S/C26H28N6.4ClH/c1-3-21(27-13-1)25-29-15-23(31-25)19-9-5-17(6-10-19)18-7-11-20(12-8-18)24-16-30-26(32-24)22-4-2-14-28-22;;;;/h5-12,15-16,21-22,27-28H,1-4,13-14H2,(H,29,31)(H,30,32);4*1H/t21-,22-;;;;/m0..../s1

2.1.3 InChI Key

AYOXSBJGFNPGNK-VDUNKYASSA-N

2.1.4 Canonical SMILES

C1CC(NC1)C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6.Cl.Cl.Cl.Cl

2.1.5 Isomeric SMILES

C1C[C@H](NC1)C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6.Cl.Cl.Cl.Cl

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 1009119-83-8

2. Hcv-in-29

3. 2-[(2s)-pyrrolidin-2-yl]-5-[4-[4-[2-[(2s)-pyrrolidin-2-yl]-1h-imidazol-5-yl]phenyl]phenyl]-1h-imidazole;tetrahydrochloride

4. 4,4'-bis(2-((s)-pyrrolidin-2-yl)-1h-imidazol-5-yl)-1,1'-biphenyl 4hcl

5. 1h-imidazole, 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2s)-2-pyrrolidinyl-, Hydrochloride (1:4)

6. 2-((2s)-pyrrolidin-2-yl)-5-(4-(4-(2- ((2s)-pyrrolidin-2-yl)-1h-imidazol -5-yl)phenyl)phenyl)-1himidazole Tetrahydrochloride

7. Ec 807-342-7

8. Amy8888

9. Mfcd28404675

10. Akos027250597

11. Ac-29069

12. Ds-11475

13. Hy-136266

14. Cs-0121086

15. A850076

16. 5,5'-(4,4'-biphenyldiyl)bis{2-[(2s)-2-pyrrolidinyl]-1h-imidazole} Tetrahydrochloride

17. 5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2s)-2-pyrrolidinyl-1h-imidazole] 4hcl

18. 5;5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2s)-2-pyrrolidinyl Hydrochloride

19. 1h-imidazole, 5,5-[1,1-biphenyl]-4,4-diylbis[2-(2s)-2-pyrrolidinyl-, Hydrochloride (1:4)

20. 1h-imidazole,5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2s)-2-pyrrolidinyl-, Hydrochloride (1:4)

21. 1h-imidazole,5,5'-[1,1'-biphenyl]-4,4'-diylbis[2-(2s)-2-pyrrolidinyl-,hydrochloride (1:4)

22. 1h-imidazole,5,5,-[1,1,-biphenyl]-4,4\'-diylbis[2-(2s)-2-pyrrolidinyl-,hydrochloride (1:4)

2.3 Create Date

2015-09-16

3 Chemical and Physical Properties

Molecular Formula	C₂₆H₃₂Cl₄N₆
Molecular Weight	570.4 g/mol
Hydrogen Bond Donor Count	8
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	5
Exact Mass	570.141306 g/mol
Monoisotopic Mass	568.144256 g/mol
Topological Polar Surface Area	81.4 Å²
Heavy Atom Count	36
Formal Charge	0
Complexity	547
Isotope Atom Count	0
Defined Atom Stereocenter Count	2
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	5